Benzaldehyde is the classic bitter-almond and cherry-smelling aromatic aldehyde that defines bitter almond oil and many almond-cherry flavor profiles. The live evidence base is strong for identity, natural occurrence, use history, and safety review in fragrance and cosmetic contexts, with more limited support for standalone bioactivity claims beyond preclinical or sensory-receptor studies. For AromaForge, benzaldehyde is best framed as a major odor-character constituent with meaningful safety context and a need to avoid overstating therapeutic effects.
Chemical identity and composition
PubChem resolves benzaldehyde to CID 240 with formula C7H6O and IUPAC name benzaldehyde. The Cosmetic Ingredient Review monograph describes it as a clear colorless to slightly yellowish oily liquid with bitter almond odor, and notes that benzaldehyde readily oxidizes to benzoic acid on exposure to air. In the archive, bitter almond essential-oil records already treat benzaldehyde as the dominant marker constituent, including specification-style assay values of 98% minimum and a current IFRA certificate citing benzaldehyde as 100.0000% of the restricted material.
Aroma and practical use
- Use the recorded bitter almond, cherry, sweet, aromatic descriptors to explore a blend's scent character; perceived strength also depends on the other ingredients.
- Review the flagged use concerns across every contributing oil and the selected dilution.
- Read the route, preparation and experimental context before using a study finding to choose an oil.
Reported benefits and effects
Findings retain their study context. An animal or laboratory result describes that experiment.
A 2019 RIFM fragrance safety assessment was published specifically for benzaldehyde, supporting that it remains an actively reviewed fragrance ingredient rather than an uncatalogued traditional material.
A 2019 RIFM fragrance safety assessment was published specifically for benzaldehyde, supporting that it remains an actively reviewed fragrance ingredient rather than an uncatalogued traditional material.
The source assessment applies to its specified exposure and preparation; this entry is not an unrestricted-use clearance.
The Cosmetic Ingredient Review re-review memo states that the original panel conclusion was that benzaldehyde is safe as used in cosmetic products, and the 2023 literature update did not identify notably different new data from the 2006 report.
The Cosmetic Ingredient Review re-review memo states that the original panel conclusion was that benzaldehyde is safe as used in cosmetic products, and the 2023 literature update did not identify notably different new data from the 2006 report.
The source assessment applies to its specified exposure and preparation; this entry is not an unrestricted-use clearance.
The same CIR materials note 2023 reported cosmetic use up to 0.2% in non-spray face and neck products, with earlier reporting up to 0.5% in perfumes.
The same CIR materials note 2023 reported cosmetic use up to 0.2% in non-spray face and neck products, with earlier reporting up to 0.5% in perfumes.
This reference does not establish a therapeutic result or a safe use level for a custom oil blend.
A 2021 preclinical paper reported that benzaldehyde reduced quinolone MICs against resistant Staphylococcus aureus strains in combination testing, indicating antibiotic-modulator activity rather than validated clinical efficacy.
A 2021 preclinical paper reported that benzaldehyde reduced quinolone MICs against resistant Staphylococcus aureus strains in combination testing, indicating antibiotic-modulator activity rather than validated clinical efficacy.
This experimental finding does not establish benefit, dose or safety in people using this blend.
Use concerns and concentration limits
Sensitization concernFlagged
Flagged in the constituent reference; assess the source, route and finished-product concentration.
Phototoxicity concernNot flagged
Not flagged in the current model. This is not proof of absence or unrestricted safety.
Oxidation concernNot flagged
Not flagged in the current model. This is not proof of absence or unrestricted safety.
Penetration enhancementNot flagged
Not flagged in the current model. This is not proof of absence or unrestricted safety.
A recorded constituent reference, not a recommended oil dilution. Product category, source applicability and all contributing oils must be checked before use.
unverified reference · No source provenance attachedThe reviewed CIR materials state that benzaldehyde is safe as used in cosmetic products and summarize current reported cosmetic uses at relatively low concentrations.
The source assessment applies to its specified exposure and preparation; this entry is not an unrestricted-use clearance.
No direct public citation is attached to this entry.
An archive-linked IFRA certificate for bitter almond natural benzaldehyde material sets a 0.06% Category 5A leave-on ceiling for that oil context, which is the strongest public dermal-use number verified in this pass.
This reference does not establish a therapeutic result or a safe use level for a custom oil blend.
No direct public citation is attached to this entry.
Benzaldehyde readily oxidizes to benzoic acid on air exposure, so oxidation and impurity control are practical handling concerns.
This reference does not establish a therapeutic result or a safe use level for a custom oil blend.
No direct public citation is attached to this entry.
Constituents it may interact with
No constituent-pair interaction is recorded for this identity. The report does not assume either amplification or incompatibility.
How the effects were investigated
oxidation to benzoic acid
A core chemistry and safety-relevant mechanism is benzaldehyde's ready oxidation to benzoic acid on exposure to air, which affects storage and impurity profile.
This reference does not establish a therapeutic result or a safe use level for a custom oil blend.
No direct public citation is attached to this entry.
trpa1 sensory activation signal
TRPA1 literature and search-visible PMC abstracts indicate benzaldehyde can act as a sensory irritant signal in TRPA1-related systems, which fits its pungent trigeminal character but is not a wellness mechanism.
This reference does not establish a therapeutic result or a safe use level for a custom oil blend.
No direct public citation is attached to this entry.
What this report cannot establish
- A reported constituent percentage does not establish an effective human therapeutic dose or the amount absorbed into the body.
- The presence of a constituent does not guarantee a clinical benefit, rash treatment or sleep improvement from a custom blend.
- An unflagged concern or missing use limit does not establish safety for ingestion, inhalation, skin exposure or a particular person.
- A candidate constituent interaction does not establish that two oils amplify one another at the selected proportions.
- Constituent descriptors alone do not establish a precise top, heart or base lifetime in a finished blend.
Known data gaps (5)
- No human efficacy evidence was verified for isolated benzaldehyde beyond safety and use-context literature.
- The strongest direct bioactivity findings located in this pass are preclinical or mechanistic rather than clinical.
- Regulatory treatment can change over time, so fragrance-limit statements beyond the cited public documents should be rechecked before reuse.
- The numeric dermal reference lacks source provenance; a verified flag alone is insufficient.
- Some findings do not record an explicit exposure route; consult the linked study before applying them to a use.